ClinicalTrials.Veeva
Menu

Find clinical trials for Multiple Sclerosis (MS) in San Francisco, CA

CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones

Related conditions:

Sclerosis
Multiple Sclerosis
Relapsing-Remitting Multiple Sclerosis
Chronic Progressive Multiple Sclerosis
Amyotrophic Lateral Sclerosis
Motor Neuron Disease
Muscle Spasticity

Multiple Sclerosis (MS) trials near San Francisco, CA, USA:

Best Available Therapy Versus Autologous Hematopoetic Stem Cell Transplant for Multiple Sclerosis (BEAT-MS) (BEAT-MS)

of Best Available Therapy (BAT) for treatment-resistant relapsing multiple sclerosis (MS). Participants will be randomized...

Enrolling
Secondary Progressive Multiple Sclerosis
Relapsing Multiple Sclerosis
Biological: Best Available Therapy (BAT)
Procedure: Autologous Hematopoietic Stem Cell Transplantation

Phase 3

National Institute of Allergy and Infectious Diseases (NIAID)
National Institute of Allergy and Infectious Diseases (NIAID)

Palo Alto, California, United States and 18 other locations

This is a Phase 1/2 study to evaluate the safety and tolerability of 18F-OP-801 in subjects with ALS, AD, MS, PD and age-matched HVs. 18F-OP...

Enrolling
Amyotrophic Lateral Sclerosis (ALS)
Multiple Sclerosis (MS)
Drug: 18F-OP-801

Phase 1, Phase 2

Ashvattha Therapeutics
Ashvattha Therapeutics

San Francisco, California, United States and 2 other locations

Newly diagnosed relapsing multiple sclerosis (MS) and high risk clinically isolated syndrome (CIS) patients will be treate...

Active, not recruiting
Relapsing Multiple Sclerosis
Clinically Isolated Syndrome
Drug: Ocrelizumab

Phase 4

University of California San Francisco (UCSF)
University of California San Francisco (UCSF)

San Francisco, California, United States

A Study of Anti-CD19 Chimeric Antigen Receptor T Cell Therapy in Subjects with Non-relapsing and Progressive Forms of Multiple Sclerosis...

Enrolling
Multiple Sclerosis
Multiple Sclerosis, Secondary Progressive
Biological: KYV-101 anti-CD19 CAR-T cell therapy
Drug: Standard lymphodepletion regimen

Phase 1

Stanford University
Stanford University

Palo Alto, California, United States

To evaluate the safety and efficacy of fingolimod vs. interferon beta-1a i.m. in pediatric patients with multiple sclerosis (MS...

Enrolling
Multiple Sclerosis
Drug: Placebo capsule
Drug: Fingolimod

Phase 3

Novartis
Novartis

San Francisco, California, United States and 107 other locations

(IV) (Part 1) and subcutaneous (SC) (Part 2) doses of RO7121932 and multiple ascending SC (Part 3) doses of RO7121932 in participants with m ...

Enrolling
Multiple Sclerosis
Drug: RO7121932 - MAD
Drug: RO7121932 SC - SAD

Phase 1

Roche
Roche

Stanford, California, United States and 23 other locations

This study will evaluate the pharmacokinetics of ocrelizumab in the breastmilk of lactating women with clinically isolated syndrome (CIS) or multiple...

Active, not recruiting
Multiple Sclerosis
Clinically Isolated Syndrome
Drug: Ocrelizumab

Phase 4

Roche
Roche

San Francisco, California, United States and 9 other locations

This study will evaluate the potential placental transfer of ocrelizumab in women with clinically isolated syndrome (CIS) or multiple sclerosis...

Active, not recruiting
Multiple Sclerosis
Clinically Isolated Syndrome
Drug: Ocrelizumab

Phase 4

Roche
Roche

San Francisco, California, United States and 10 other locations

Status recently updated

The goal of this study is to test a drug called KYV-101 in people who have progressive multiple sclerosis (MS) and who hav...

Not yet enrolling
Enrolling
Progressive Multiple Sclerosis
Biological: KYV-101 (Biological) - 1 ×10^8 cells
Drug: Chemotherapy: fludarabine (FLU)

Phase 1

Bruce Cree

San Francisco, California, United States

with fingolimod in children and adolescents with relapsing-remitting multiple sclerosis aged between 10 and \< 18 years over a dura...

Enrolling
Relapsing-Remitting Multiple Sclerosis
Other: Ocrelizumab Placebo
Drug: Ocrelizumab

Phase 3

Roche
Roche

San Francisco, California, United States and 118 other locations

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems